Alternatives to Abcam

Developing and manufacturing laminin-based cell culture substrates for advanced cell therapies and drug discovery.

Developer and manufacturer of antibodies and reagents for biomedical research.

A biotechnology ecosystem company powering the future of drug discovery and development through AI-driven platforms and integrated services.

Global supplier of research reagents including antibodies, proteins, and ELISA kits.

Biotechnology company developing transformative gene-based medicines using CRISPR/Cas9 gene editing technology.

Integrated life science company specializing in diagnostic testing solutions and life science raw materials.

Biotechnology firm specializing in antibody development, production, and biological research tools.

AI-powered insurance solutions for homeowners, focusing on water damage prevention.

Biotechnology services company specializing in antibody discovery and development.

Moderna is a biotechnology company pioneering mRNA medicine, best known for its COVID-19 vaccine and a broad pipeline of mRNA-based therapeutics.

Biotechnology company leveraging ultracompact CRISPR systems for gene editing therapies and diagnostics.

Spatial multiomics company developing technologies for single-cell gene expression profiling in intact tissues.

A vertically-integrated procurement platform for the life sciences industry.

A global leader in clinical pharmacology and bioanalytical sciences.

Freenome is a biotechnology company developing a multi-cancer early detection blood test using machine learning and biology.

AI-powered knowledge discovery for life sciences.

Developing novel immunotherapies and diagnostics for cancer.

A University of Cambridge spin-out tackling unmet drug screening needs by combining materials engineering and cell biology.

Pioneering vision restoration therapies for severe retinal degenerations.

Platform designed to cut cell and gene therapy production costs.

The first Integrated Development and Manufacturing Organization (IDMO) for cell therapies.

Revolutionizing genomic analysis with innovative sequencing technology.

Unlocking industrial-scale RNA-seq for primary drug screening and toxicology.

Developing microbiome-based therapeutics to address underlying disease biology, particularly in gastrointestinal health.

Develops and distributes bioreactor technology for stem cell cultivation.

AI-driven biotechnology company developing novel protein therapeutics through generative biology.

AI-enabled technology for cell biology research and biopharma development.

Clinical-stage biopharmaceutical company developing novel boron-based small molecule therapeutics for rare infectious diseases and oncology.

Biopharmaceutical company developing best-in-class medicines for autoimmune and rare diseases, with a focus on thyroid eye disease.

Advancing biopsy specimen stewardship and expanding access to precision oncology.

Developing human microbiology models for drug discovery.

Developing an automated platform for liquid biopsy sample preparation.

AI safety and research company building reliable, interpretable, and steerable AI systems.

Global biopharmaceutical company pioneering mRNA-based immunotherapies and vaccines for cancer and infectious diseases.

Global leader in life sciences, diagnostics, and applied chemical markets.

AI-driven drug discovery spinoff from DeepMind using AlphaFold to discover novel medicines.

AI-powered precision testing for patient identification in clinics and clinical trials.

Personalizing cancer care through a novel, physics-informed approach to predict tumor response to therapy.

Advancing next-generation mRNA medicines.

Developing AI-powered diagnostics for neurodegenerative diseases.

Clinical-stage biotechnology company advancing molecular glue degrader (MGD) medicines.

AI-powered antibody discovery platform.

Developing highly targeted, small molecule medicines.

Clinical-stage biopharmaceutical company developing microbiome-derived immunotherapies for cancer and immune diseases.

Immunotherapy company targeting oncology and autoimmune diseases.

Developing first-and best-in-class antibody-drug conjugates (ADCs) for cancers with high unmet medical need.

A biotechnology company focused on oncology drug discovery.

Clinical-stage biopharmaceutical company leveraging a proprietary platform to discover and develop novel precision medicines from fungi.

Clinical-stage biopharmaceutical company developing next-generation therapies for obesity and cardiometabolic diseases.

A clinical-stage biotechnology company developing inobrodib as a first-in-class, oral p300/CBP inhibitor for the treatment of multiple myeloma.

Biopharmaceutical company developing novel small-molecule therapeutics for rare kidney diseases, particularly Autosomal Dominant Polycystic Kidney Disease (ADPKD).

Global leader in serving science, providing analytical instruments, consumables, and services for research, diagnostics, and manufacturing.

Biotechnology company developing novel therapeutics by harnessing the autophagy pathway to treat serious diseases.

BreezeBio is a genetic medicine company developing a pipeline of precision therapeutics.

A biotechnology company developing genetic therapies for rare disorders.

A clinical-stage biopharmaceutical company developing novel immunotherapies.

A clinical-stage biopharmaceutical company developing novel therapies for neurological disorders.

A full-stack spatial biology company.